Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). - Takabatake,D.; Fujita,T.; Shien,T.; Kawasaki,K.; Taira,N.; Yoshitomi,S.J.; Takahashi,H.; Ishibe,Y.; Ogasawara,Y.; Doihara,H. (Int J Cancer, 2006)